A study of first line therapy with esomeprazol for Helicobacter pylori eradication

Trial Profile

A study of first line therapy with esomeprazol for Helicobacter pylori eradication

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Dec 2014

At a glance

  • Drugs Esomeprazole (Primary)
  • Indications Helicobacter pylori infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jan 2014 Status changed from recruiting to active, no longer recruiting as per University Hospital Medical Information Network - Japan record.
    • 23 Jan 2013 New trial record
    • 07 Jan 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top